Evidence map›Paper›PMID 25587010›Full record

ArticlemBio2015

Genomic avenue to avian colisepticemia.

Sagi Huja, Yaara Oren, Eva Trost, Elzbieta Brzuszkiewicz, Dvora Biran, Jochen Blom, Alexander Goesmann, Gerhard Gottschalk, Jörg Hacker, Eliora Z Ron and 1 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Avian PathogenicVeterinary sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Genetic Diversity and Antimicrobial Resistance of ExtraintestinalAnimals : an open access journal from MDPI · 2023
    Article
  14. Article
  15. Article
  16. Molecular and Serological Characteristics of Avian PathogenicAnimals : an open access journal from MDPI · 2022
    Article
  17. Transcriptional Regulation ofInternational journal of molecular sciences · 2022
    Article
  18. Article
  19. Review
  20. Surviving Serum: the Escherichia coliInfection and immunity · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Sagi HujaDepartment of Molecular Microbiology and Biotechnology, Tel Aviv University, Tel Aviv, Israel.
Yaara OrenDepartment of Cell Biology, Tel Aviv University, Tel Aviv, Israel.
Eva TrostInstitute of Hygiene, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Elzbieta BrzuszkiewiczGöttingen Genomics Laboratory, Institute of Microbiology and Genetics, Georg-August-University, Göttingen, Germany.
Dvora BiranDepartment of Molecular Microbiology and Biotechnology, Tel Aviv University, Tel Aviv, Israel.
Jochen BlomComputational Genomics, Center for Biotechnology (CeBiTec), University of Bielefeld, Bielefeld, Germany.
Alexander GoesmannComputational Genomics, Center for Biotechnology (CeBiTec), University of Bielefeld, Bielefeld, Germany.
Gerhard GottschalkGöttingen Genomics Laboratory, Institute of Microbiology and Genetics, Georg-August-University, Göttingen, Germany.
Jörg HackerNational German Academy of Sciences Leopoldina, Halle, Saale, Germany.
Eliora Z Ronulrich.dobrindt@ukmuenster.de eliora@post.tau.ac.il.
Ulrich DobrindtInstitute of Hygiene, Westfälische Wilhelms-Universität Münster, Münster, Germany ulrich.dobrindt@ukmuenster.de eliora@post.tau.ac.il.
Tel Aviv University · ILBielefeld University · DEUniversity of Göttingen · DEUniversity of Münster · DEGerman National Academy of Sciences Leopoldina · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledHere we present an extensive genomic and genetic analysis of Escherichia coli strains of serotype O78 that represent the major cause of avian colisepticemia, an invasive infection caused by avian pathogenic Escherichia coli (APEC) strains. It is associated with high mortality and morbidity, resulting in significant economic consequences for the poultry industry. To understand the genetic basis of the virulence of avian septicemic E. coli, we sequenced the entire genome of a clinical isolate of serotype O78-O78:H19 ST88 isolate 789 (O78-9)-and compared it with three publicly available APEC O78 sequences and one complete genome of APEC serotype O1 strain. Although there was a large variability in genome content between the APEC strains, several genes were conserved, which are potentially critical for colisepticemia. Some of these genes are present in multiple copies per genome or code for gene products with overlapping function, signifying their importance. A systematic deletion of each of these virulence-related genes identified three systems that are conserved in all septicemic strains examined and are critical for serum survival, a prerequisite for septicemia. These are the plasmid-encoded protein, the defective ETT2 (E. coli type 3 secretion system 2) type 3 secretion system ETT2sepsis, and iron uptake systems. Strain O78-9 is the only APEC O78 strain that also carried the regulon coding for yersiniabactin, the iron binding system of the Yersinia high-pathogenicity island. Interestingly, this system is the only one that cannot be complemented by other iron uptake systems under iron limitation and in serum. IMPORTANCE: Avian colisepticemia is a severe systemic disease of birds causing high morbidity and mortality and resulting in severe economic losses. The bacteria associated with avian colisepticemia are highly antibiotic resistant, making antibiotic treatment ineffective, and there is no effective vaccine due to the multitude of serotypes involved. To understand the disease and work out strategies to combat it, we performed an extensive genomic and genetic analysis of Escherichia coli strains of serotype O78, the major cause of the disease. We identified several potential virulence factors, conserved in all the colisepticemic strains examined, and determined their contribution to growth in serum, an absolute requirement for septicemia. These findings raise the possibility that specific vaccines or drugs can be developed against these critical virulence factors to help combat this economically important disease.

Indexed as

Genome, BacterialAnimalsChickensEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsGenomicsMolecular Sequence DataPhylogenyPoultry DiseasesSepsisTurkeysVirulence FactorsEscherichia coli ProteinsVirulence Factors

Identifiers

PMID25587010
PMCPMC4313913
OpenAlexW2129113812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.